Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

From Here to 2010

Key Market Moves in Pharma’s Top 10 Therapeutic Categories

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    Table I

    References

    1. 1.

      Pharmaceutical therapeutic category forecasts: analysis of global top 10 therapeutic categories. New York: Lehman Brothers Global Equity Research, 2006

    2. 2.

      Incretin-targeting technologies for type 2 diabetes: dipeptidyl peptidase IV inhibitors and glucagon-like peptide-1 analogs. Pharmaceutical & Diagnostic Innovation. 2006; 4 (7): 3–7

    3. 3.

      Hypertension revolution or just hype?. First renin inhibitor close to market. Pharmaceutical & Diagnostic Innovation. 2006; 4 (4): 7–9

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    From Here to 2010. Pharmaceutical & Diagnostic Innovation 4, 8–11 (2006). https://doi.org/10.1007/BF03259661

    Download citation

    Keywords

    • Chronic Obstructive Pulmonary Disease
    • Insulin Glargine
    • Sitagliptin
    • Aliskiren
    • Cholesteryl Ester Transfer Protein